摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(benzhydrylthio)propanamide | 135468-50-7

中文名称
——
中文别名
——
英文名称
3-(benzhydrylthio)propanamide
英文别名
3-Benzhydrylsulfanylpropanamide
3-(benzhydrylthio)propanamide化学式
CAS
135468-50-7
化学式
C16H17NOS
mdl
——
分子量
271.383
InChiKey
WYCKWWJZURDUET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    68.4
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(benzhydrylthio)propanamidesodium氯化铵 作用下, 以31%的产率得到3-[(3-氨基-3-氧代丙基)二硫代]丙酰胺
    参考文献:
    名称:
    Nitridoosmium(VI) and nitridoruthenium(VI) complexes of cysteine(2-) and related ligands
    摘要:
    Anionic complexes of nitridoruthenium(VI) and nitridoosmium(VI) containing covalently bound N-acetyl-L-cysteinato, 3-sulfidopropionato, and 3-sulfidopropionamidato ligands have been synthesized to model the binding of delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine to the iron center in the metalloenzyme isopenicillin N synthetase. The complexes are prepared by the reaction of N-acetyl-L-cysteine, 3-mercaptopropionic acid, and 3-mercaptopropionamide with [NBu(n)4][Os(N)(OSiMe3)4], [NBu(n)4][Os(N)Cl4], [NBu(n)4][Ru(N)(CH2SiMe3)4], or [NBu(n)4][Ru(N)(OSiMe3)4]. They have been characterized by elemental analysis and IR and NMR spectroscopy. Spectroscopic data show that the N-acetyl-L-cysteinato and 3-sulfidopropionato ligands are bound to the metal center through sulfur and oxygen, while the 3-sulfidopropionamidato ligands are bound through sulfur and nitrogen. The molecular structures of cis-[NBu(n)4][Os(N)(O2CCH2CH2S)2], [NBu(n)4][Os(N){O2CCH(NHCOCH3)CH2S}2], and [PPh4][Ru(N)(NHCOCH2CH2S)2)] were determined by single-crystal X-ray diffraction. These complexes were found to have distorted square-pyramidal geometry around the metal center. cis-[NBu(n)4][Os(N)(O2CCH2CH2S)2] crystallizes in monoclinic space group P2(1)/c with a = 13.718 (6) angstrom, b = 10.080 (3) angstrom, c = 19.890 (5) angstrom, beta = 92.16 (3) angstrom, and Z = 4. [NBu(n)4][Os(N){L-O2CCH(NHCOCH3)CH2S}2] crystallizes in monoclinic space group C2 with a = 18.371 (6) angstrom, b = 9.261 (1) angstrom, c = 21.125 (7) angstrom, beta = 102.92 (3) angstrom, and Z = 4. [PPh4][Ru(N)(NHCOCH2CH2S)2)] crystallizes in orthorhombic space group Pbca with a = 23.022 (1) angstrom, b = 16.120 (1) angstrom, c = 15.728 (1) angstrom, and Z = 8.
    DOI:
    10.1021/ja00016a031
  • 作为产物:
    描述:
    参考文献:
    名称:
    Nitridoosmium(VI) and nitridoruthenium(VI) complexes of cysteine(2-) and related ligands
    摘要:
    Anionic complexes of nitridoruthenium(VI) and nitridoosmium(VI) containing covalently bound N-acetyl-L-cysteinato, 3-sulfidopropionato, and 3-sulfidopropionamidato ligands have been synthesized to model the binding of delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine to the iron center in the metalloenzyme isopenicillin N synthetase. The complexes are prepared by the reaction of N-acetyl-L-cysteine, 3-mercaptopropionic acid, and 3-mercaptopropionamide with [NBu(n)4][Os(N)(OSiMe3)4], [NBu(n)4][Os(N)Cl4], [NBu(n)4][Ru(N)(CH2SiMe3)4], or [NBu(n)4][Ru(N)(OSiMe3)4]. They have been characterized by elemental analysis and IR and NMR spectroscopy. Spectroscopic data show that the N-acetyl-L-cysteinato and 3-sulfidopropionato ligands are bound to the metal center through sulfur and oxygen, while the 3-sulfidopropionamidato ligands are bound through sulfur and nitrogen. The molecular structures of cis-[NBu(n)4][Os(N)(O2CCH2CH2S)2], [NBu(n)4][Os(N){O2CCH(NHCOCH3)CH2S}2], and [PPh4][Ru(N)(NHCOCH2CH2S)2)] were determined by single-crystal X-ray diffraction. These complexes were found to have distorted square-pyramidal geometry around the metal center. cis-[NBu(n)4][Os(N)(O2CCH2CH2S)2] crystallizes in monoclinic space group P2(1)/c with a = 13.718 (6) angstrom, b = 10.080 (3) angstrom, c = 19.890 (5) angstrom, beta = 92.16 (3) angstrom, and Z = 4. [NBu(n)4][Os(N){L-O2CCH(NHCOCH3)CH2S}2] crystallizes in monoclinic space group C2 with a = 18.371 (6) angstrom, b = 9.261 (1) angstrom, c = 21.125 (7) angstrom, beta = 102.92 (3) angstrom, and Z = 4. [PPh4][Ru(N)(NHCOCH2CH2S)2)] crystallizes in orthorhombic space group Pbca with a = 23.022 (1) angstrom, b = 16.120 (1) angstrom, c = 15.728 (1) angstrom, and Z = 8.
    DOI:
    10.1021/ja00016a031
点击查看最新优质反应信息

文献信息

  • [EN] ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE<br/>[FR] CATALYSE PAR PAIRE D'IONS DE TUNGSTATE ET DE MOLYBDATE
    申请人:UNIV NANYANG TECH
    公开号:WO2017164813A1
    公开(公告)日:2017-09-28
    D The present invention relates to ion pair catalysts (I) comprising the cationic bisguanidinium ligand (A) and diperoxomolybdate anion (B). The present invention also relates to ion pair catalysts (III) comprising the cationic bisguanidinium ligand (C) and peroxotungstate anion (D). It further relates to the use of the said catalysts in the manufacture of enantiomerically enriched sulfoxides.
    本发明涉及离子对催化剂(I),包括阳离子双胍基配体(A)和过氧钼酸根离子(B)。本发明还涉及离子对催化剂(III),包括阳离子双胍基配体(C)和过氧钨酸根离子(D)。此外,本发明还涉及所述催化剂在合成对映富集亚砜中的应用。
  • Ion pair catalysis of tungstate and molybdate
    申请人:Nanyang Technological University
    公开号:US10710061B2
    公开(公告)日:2020-07-14
    D The present invention relates to ion pair catalysts (I) comprising the cationic bisguanidinium ligand (A) and diperoxomolybdate anion (B). The present invention also relates to ion pair catalysts (III) comprising the cationic bisguanidinium ligand (C) and peroxotungstate anion (D). It further relates to the use of the said catalysts in the manufacture of enantiomerically enriched sulfoxides.
    D 本发明涉及由阳离子双胍配体(A)和二氧钼酸阴离子(B)组成的离子对催化剂(I)。本发明还涉及由阳离子双胍配体(C)和过氧钨酸盐阴离子(D)组成的离子对催化剂(III)。本发明还涉及上述催化剂在制造对映体富集的硫氧化物中的用途。
  • ION PAIR CATALYSIS OF TUNGSTATE AND MOLYBDATE
    申请人:Nanyang Technological University
    公开号:US20190105646A1
    公开(公告)日:2019-04-11
    The present invention relates to ion pair catalysts (I) comprising the cationic bisguanidinium ligand (A) and diperoxomolybdate anion (B). The present invention also relates to ion pair catalysts (III) comprising the cationic bisguanidinium ligand (C) and peroxotungstate anion (D). It further relates to the use of the said catalysts in the manufacture of enantiomerically enriched sulfoxides.
  • [EN] PROCESS FOR THE PREPARATION OF 2-[(DIPHENYLMETHYL) THIO] ACETAMIDE<br/>[FR] PROCEDE DE PREPARATION DE 2-[(DIPHENYLMETHYL)THIOACETAMIDE
    申请人:ALEMBIC LTD
    公开号:WO2004075827A2
    公开(公告)日:2004-09-10
    Process for the preparation of 2-[(diphenylmethyl)thioacetamide, an intermediate for the preparation of Modafinil which is a CNS stimulant and used for the treatment of narcolepsia. The process comprises reacting 2-[(diphenylmethyl)thio]acetic acid with alcohols, in presence of catalytic amount of inorganic acid or organic acid at reflux temperature of alcohol to obtain corresponding ester which is reacted with ammonia to give 2-[(diphenylmethyl)thio]acetamide. If desired 2-[(diphenylmethyl)thioacetamide thus produced is reacted with hydrogen peroxide to produce Modafinil.
  • 10.1021/acs.orglett.4c02452
    作者:Huth, Susannah E.、Tampellini, Nicolò、Guerrero, Maria D.、Miller, Scott J.
    DOI:10.1021/acs.orglett.4c02452
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐